Fig 1.
Cinacalcet initiation during the follow-up period, and mean hemoglobin level by time-varying cinacalcet status (user or non-user).
Table 1.
Characteristics of the cinacalcet non-users at registry enrollment and of the cinacalcet initiators at the visit immediately prior to cinacalcet initiation.
Fig 2.
Trajectories of laboratory findings and medication use for the cinacalcet users before and after cinacalcet initiation.
Table 2.
Unadjusted and adjusted effects of each 6 additional months of cinacalcet therapy on the odds of achieving the treatment target (intention-to-treat effect).
Table 3.
Unadjusted and adjusted effects of each 6 additional months of cinacalcet therapy on hemoglobin levels (intention-to-treat effect).